Amlitelimab, an OX40 ligand–targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, ...

Alphabet is rated a Buy, as it is poised for a strong Q4 2025, driven by robust cloud and advertising growth. Click here for ...

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...

Background Although 90% of youth live in low- and middle-income countries, only 10% of child mental health research is ...

Testosterone Replacement Therapy (TRT) has emerged as a critical treatment for men experiencing low testosterone levels, a ...

The most striking finding in recent oncological research is the significant gain in survival rates for cancers previously ...

Rugby needs less regurgitation and more imagination as an epidemic of copy-and-paste coaching spreads across the world ...

NO.568.SIMING EAST ROAD,YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE, CHINA, January 16, 2026 /EINPresswire.com/ -- ...

BC Conservation Officers are reporting 2025 saw the lowest number of black bears put down in more than a decade. Officers ...

The price of natural gas jumped this week ahead of a significant winter storm slated to hit large swaths of the country this ...

Despite higher construction prices, Property Valuation Administrator Bill Dunn said 125 permits for new homes were awarded in 2025, up from 88 in 2024.